Quantitative U.S. Total Market Equity Portfolio CPRX Holdings History
Quantitative U.S. Total Market Equity Portfolio's Catalyst Pharmaceuticals Inc Holding Summary
As of 2025-01-31, GLENMEDE FUND INC held 38,660.00 shares of Catalyst Pharmaceuticals Inc(CPRX), totaling $872,170.00. This investment constitutes 2.67% of their stock portfolio, and GLENMEDE FUND INC now holds 0.03% of the outstanding Catalyst Pharmaceuticals Inc(CPRX) stock.
The initial trade took place in 2023Q4. And since then Quantitative U.S. Total Market Equity Portfolio has made 1 purchases of CPRX, at an average price of $13.21, for a total of 38,660.00 shares. Based on historical transaction data and CPRX's current price of $22.81, Quantitative U.S. Total Market Equity Portfolio's estimated gain on his CPRX holdings is $371,136.00, reflecting a 72.67% gain to date.
Quantitative U.S. Total Market Equity Portfolio CPRX ($22.81) Holding Chart
Quantitative U.S. Total Market Equity Portfolio CPRX ($22.81) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
